Navigation Links
Synthetic Biologics Reports Third Quarter 2012 Financial Results
Date:11/14/2012

filings with the SEC. The information in this release is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

 Synthetic Biologics, Inc. and Subsidiaries(in thousands, except share data)Condensed Consolidated Balance SheetsSeptember 30,December 31,20122011(Unaudited)(Audited)AssetsCash

$
4,577$
,678Accounts receivable, net

122405Other

15116Assets of discontinued operations

-23Property and equipment, net

249323Long-term note receivable

700-Deposits and other assets

2731Total assets

$
5,826$
7,476Liabilities and Stockholders' EquityCurrent liabilities

$
417$
417Stockholders' equity

5,4097,059Total liabilities and stockholders' equity

$
5,826$
7,476 Condensed Consolidated Statements of Operations (Unaudited)For the three months ended
September 30,For the nine months ended
September 30,2012201120122011Operating Costs and ExpensesGeneral and administrative

$
,073$
582$
3,717$
2,339Research and development

7632891,696801Total operating costs and expenses

1,8368715,4133,140Loss from Continuing Operations(1,836)(871)(5,413)(3,140)Other Income (Expense)Warrant expense  

---(1,492)Change in fair value of warrant liability

-(165)-(242)Other income (expense)

1062255Total other income (expense), net

10(159)22(1,679)Loss from Continuing Operations(1,826)(1,030)(5,391)(4,819)Income (Loss) from Discontinued Operations(104)(68)389(145)Net Loss and Comprehensive Loss$
(1,930)$
(1,098)$
(5,002)$
(4,964)Net Income (Loss) Per Share - Basic and DilutiveContinuing Operations

$
(0.05)$
(0.04)$
(0.16)$
(0.18)Discontinued Oper
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Synthetic Biologics to Acquire Clinical-Stage C. difficile Infectious Disease Program
2. Taming mavericks: Stanford researchers use synthetic magnetism to control light
3. Synthetic Biologics Completes $10.8 Million Private Placement Financing
4. Synthetic Biologics Announces $10.8 Million Financing
5. Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
6. Synthetic Biology Market is Expected to Reach USD 16.7 Billion Globally in 2018: Transparency Market Research
7. Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases
8. Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer
9. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
10. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
11. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 iLab Solutions, the leader in ... new Director of Product Strategy. In this role, Michelle will ... sub-teams to guide in the development of iLab products. Her ... maximum possible benefit to the scientific community by offering the ...
(Date:1/14/2014)... Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), ... commercializing innovative therapies addressing major unmet medical needs ... the Notice of Allowance from the United States ... RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. ...
(Date:1/14/2014)... 14, 2014   Kinaxis ®, provider of RapidResponse ®, ... and operations planning ( S&OP ) service, is proud to ... which will be held at the Hilton San Diego Bayfront, ... customer Elisabeth Kaszas , Director of Supply Chain at ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental ... about dual arch impressions on its dental blog. ... blog entry serves up a list of tips to help ... by Dr. David Little as he crafts a porcelain crown ...
Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Ind. - Researchers have overcome a major obstacle in ... create a new class of electronics that would be ... nanotubes, which were discovered in the early 1990s, could ... well as ultra-thin "nanowires" for electronic circuits. The nanotubes ...
... Thomson Reuters announced today the publication of a ... interested in entering the Japanese generic drug market. ... market: opportunities and strategies for success," notes that a ... rapidly aging population and wide-ranging government initiatives to reduce ...
... Mass., Oct. 1 Idenix Pharmaceuticals, Inc. (Nasdaq: ... and development of drugs for the treatment of human ... the company,s lead hepatitis C development program, have been ... the American Association for the Study of Liver Diseases ...
Cached Biology Technology:Better control of carbon nanotube 'growth' promising for future electronics 2Better control of carbon nanotube 'growth' promising for future electronics 3Thomson Reuters Explores the Opportunities and Challenges of Entering the Japanese Generic Drug Market 2Thomson Reuters Explores the Opportunities and Challenges of Entering the Japanese Generic Drug Market 3Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) 2Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) 3
(Date:4/17/2014)... One day about eight years ago, Katia Silvera ... and her father were on a field trip in a ... orchid they had never seen before. , Unable to identify ... The orchid turned out to be an unnamed species. ... silverarum . , "Lophiaris" is the genus name, comprising about ...
(Date:4/17/2014)... Several parasites and pathogens that devastate honeybees in Europe, ... Africa, but do not appear to be impacting native ... team of researchers., The invasive pests include including ... East African honeybees appear to be resilient to these ... used to control pests in Europe, Asia and the ...
(Date:4/17/2014)... such as heart disease, epilepsy and pain, making them ... is still much scientists do not know about the ... into the structure of sodium channels and, specifically, one ... responsible for ,fine-tuning, the activity of the channel. The ... the Journal of Biological Chemistry . , Nerves ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3Structure of sodium channels different than previously believed 2
... and evolution of humanity, from early hominid to dominant ... but of our planet. To chronicle this epic narrative ... from the George Washington University, presents the Wiley-Blackwell Encyclopedia ... understanding of mankind,s ancient history. Over two ...
... has been developed to carry out preimplantation genetic screening ... to the recipient uterus in the same in vitro ... The technique has been applied to the ... age, recurrent miscarriages or repeated implantation failures. ...
... 2011 Lockheed Martin (NYSE: LMT ) ... Integrations "Company of the Year" by Frost and Sullivan, ... that offer high levels of customer value. ... biometric solutions that play an important role our customer,s ...
Cached Biology News:Improvements in embryonic preimplantation genetic screening techniques 2Lockheed Martin Named Biometrics "Company of the Year" by Frost and Sullivan 2
... BioChains human adult normal Mega Western ... proprietary technology. The Mega Western Protein Arrays ... lysates from documented tissue sources. A protein ... well electrophoresesed along with a Protein molecular ...
... applications not requiring confocal, the BD Pathway ... the Pathway 435. And, the Pathway 415 ... applications require it. High-performance, ... to use the laser autofocus, camera autofocus, ...
fully automated system for the processing of microarrays on microscope slides...
... containing Dermal Fibroblasts (rabbit) and media. Cryo-preserved ... 10% DMSO at passage 25 (approx), supplied ... cell culture is supplied as a long-term ... additional 6 months of continuous growth from ...
Biology Products: